Finerenone: Reducing Progressive Kidney Dysfunction and Secondary Cardiovascular Complications in Patients With Chronic Kidney Disease Associated With Type 2 Diabetes

被引：0
|
作者：
Beacom, Robin E. [1 ]
Blankenship, James K. [2 ]
Harrington, Deedra H. [2 ]
机构：
[1] Univ Louisiana Lafayette, Coll Nursing & Hlth Sci, Lafayette, LA 70504 USA
[2] Univ Louisiana, Coll Nursing & Hlth Sci, Lafayette, LA USA
来源：
JNP- THE JOURNAL FOR NURSE PRACTITIONERS | 2022年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.nurpra.2022.04.009
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
[No abstract available]
引用
收藏
页码：800 / 801
页数：2
相关论文
共 50 条
  • [21] The potential role of finerenone in patients with type 1 diabetes and chronic kidney disease
    Vasco, Maria Adelaida Escobar
    Fantaye, Samuel H.
    Raghunathan, Sapna
    Solis-Herrera, Carolina
    DIABETES OBESITY & METABOLISM, 2024, 26 (10): : 4135 - 4146
  • [22] FINERENONE AND CHRONIC KIDNEY DISEASE OUTCOMES IN HISPANIC PATIENTS WITH TYPE 2 DIABETES: A FIDELITY ANALYSIS
    Rosas, Sylvia
    Ruilope, Luis M.
    Anker, Stefan D.
    Pitt, Bertram
    Rossing, Peter
    Bonfanti, Andres A. C.
    Correa-Rotter, Ricardo
    Gonzalez, Fernando
    Pergola, Pablo
    Umpierrez, Guillermo
    Scalise, Andrea
    Scott, Charlie
    Joseph, Amer
    Bakris, George L.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 79 (04) : S47 - S48
  • [23] FINERENONE AND CHRONIC KIDNEY DISEASE OUTCOMES IN BLACK PATIENTS WITH TYPE 2 DIABETES: A FIDELITY ANALYSIS
    Flack, John M.
    Agarwal, Rajiv
    Anker, Stefan D.
    Pitt, Bertram
    Ruilope, Luis M.
    Rossing, Peter
    Alder, Sharon
    Fried, Linda
    Jamerson, Kenneth
    Toto, Robert
    Brinker, Meike
    Farjat, Alfredo E.
    Kolkhof, Peter
    Joseph, Amer
    Bakris, George
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 79 (04) : S20 - S20
  • [24] Outcomes With Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Baseline Insulin Resistance
    Ebert, Thomas
    Anker, Stefan D.
    Ruilope, Luis M.
    Fioretto, Paola
    Fonseca, Vivian
    Umpierrez, Guillermo E.
    Birkenfeld, Andreas L.
    Lawatscheck, Robert
    Scott, Charlie
    Rohwedder, Katja
    Rossing, Peter
    DIABETES CARE, 2024, 47 (03) : 362 - 370
  • [25] Finerenone and left ventricular hypertrophy in chronic kidney disease and type 2 diabetes
    Filippatos, Gerasimos
    Anker, Stefan D.
    Bakris, George L.
    Rossing, Peter
    Ruilope, Luis M.
    Coats, Andrew J. S.
    von Haehling, Stephan
    Ponikowski, Piotr
    Rosano, Giuseppe M. C.
    Brinker, Meike
    Farjat, Alfredo E.
    Roberts, Luke
    Pitt, Bertram
    ESC HEART FAILURE, 2025, 12 (01): : 185 - 188
  • [26] FINERENONE ADDED TO TREATMENT GUIDELINES FOR TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2023, 123 (05) : 23 - 23
  • [27] Effect of finerenone in patients with diabetes and advanced chronic kidney disease
    Mori, Daisuke
    Tamai, Shinjiro
    Nomi, Hiroki
    Nagatoya, Katsuyuki
    Yamauchi, Atsushi
    JOURNAL OF NEPHROLOGY, 2025,
  • [28] Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis (vol 43, pg 474, 2022)
    Agarwal, Rajiv
    Filippatos, Gerasimos
    Pitt, Bertram
    Anker, Stefan D.
    Rossing, Peter
    Joseph, Amer
    Kolkhof, Peter
    Nowack, Christina
    Gebel, Martin
    Ruilop, Luis M.
    Bakris, George L.
    EUROPEAN HEART JOURNAL, 2022, 43 (20) : 1989 - 1989
  • [29] The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study
    Rossing, Peter
    Anker, Stefan D. D.
    Filippatos, Gerasimos
    Pitt, Bertram
    Ruilope, Luis M. M.
    Billings, Liana K. K.
    Green, Jennifer B. B.
    Koya, Daisuke
    Mosenzon, Ofri
    Pantalone, Kevin M. M.
    Ahlers, Christiane
    Lage, Andrea
    Lawatscheck, Robert
    Scalise, Andrea
    Bakris, George L. L.
    DIABETES OBESITY & METABOLISM, 2023, 25 (10): : 2989 - 2998
  • [30] Letter by Lother et al Regarding Article, "Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes"
    Lother, Achim
    Bode, Christoph
    Hein, Lutz
    CIRCULATION, 2021, 144 (11) : E201 - E201
12345